Sabtu, 19 Maret 2022

Google Alert - Business

Google
Business
Daily update March 20, 2022
NEWS
The New York Times
Climate scientists, oil executives, progressives and conservatives all agree on one thing these days: The energy transition is upon us. The uninhibited burning of fossil fuels for more than a century has already warmed the planet significantly, ...
Facebook Twitter Flag as irrelevant
Fortune
Stocks recovered from an early slide on Wall Street and closed broadly higher Friday, notching their biggest weekly gain in 16 months. The S&P 500 rose for the fourth straight day, adding 1.2% ...
Facebook Twitter Flag as irrelevant
Fortune
"The crisis in Ukraine is of grave concern, and we strongly support a diplomatic solution," said Lorenzo Simonelli, chairman and CEO of Baker Hughes. Halliburton announced Friday that it ...
Facebook Twitter Flag as irrelevant
The New York Times
The companies said the changes would eliminate up to 70 percent of the medical debt accounts on consumers' credit reports, which contain reams of data used to calculate the all-important three-digit credit score that is the key to mortgages, car loans, ...
Facebook Twitter Flag as irrelevant
The Washington Post
These transactions would expose fiduciaries to liability, and plan participants to the risks of inadequate disclosures and the loss of investor protections that are guaranteed under the securities laws. The Department also cited to warnings from the ...
Facebook Twitter Flag as irrelevant
Fortune
The automaker has recalled Atlas SUVs from the model years 2019 through 2023, as well as the 2020–2023 Atlas Cross Sport. Some drivers have reported that their warning lights and alarms would go off, ...
Facebook Twitter Flag as irrelevant
CBC.ca
The company announced Friday that it will expand the number of people it employs at its Exchange District studio to 300 from 100 by 2030 by hiring additional programmers. The France-based company is best known for ...
Facebook Twitter Flag as irrelevant
ABC News
Britain's medicines regulator has approved AstraZeneca's antibody-based COVID-19 treatment for preventing infections in adults with a poor immune response, marking a major step in the fight against the pandemic as infections surge globally.
Facebook Twitter Flag as irrelevant
See more results | Edit this alert
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback

Tidak ada komentar:

Posting Komentar